Keratoacanthoma is a fast-growing skin growth that usually appears on sun-exposed skin, often in older adults. It often looks like a round, dome-shaped bump with a central plug of keratin, and some people notice tenderness or mild pain. Keratoacanthoma usually develops over weeks, and some lesions may shrink on their own over a few months, but doctors often treat it because it can be hard to tell apart from a type of skin cancer called squamous cell carcinoma. Not everyone will have the same experience. Treatment for keratoacanthoma commonly involves surgical removal, and death from a typical skin lesion is very rare, though careful medical review matters because of its similarity to more dangerous skin cancers.
How many people live with Keratoacanthoma?
Worldwide and U.S. estimates for how many people are living with keratoacanthoma are not consistently reported by a single authoritative source. This condition is usually described in smaller regional studies or grouped with other skin cancers, so there is no reliable global total or U.S. total that can be stated with confidence.
Overview
KeratoacanthomaSymptoms
Keratoacanthoma usually appears as a fast-growing, dome-shaped skin lump with a central plug of keratin. It often develops over a few weeks on sun-exposed skin, especially the face, hands, or arms, and may feel tender.
Outlook and prognosis
Keratoacanthoma often grows quickly over a few weeks, then may shrink on its own over months. Even so, doctors usually remove it because it can look like skin cancer. With treatment, the outlook is usually excellent.
Causes and risk factors
Keratoacanthoma is linked mainly to long-term ultraviolet exposure, especially in fair skin and older age. Risk also rises with previous skin injury, certain chemical exposures, a weakened immune system, and sometimes an inherited tendency.
Genetic influences
Genetics usually are not the main driver of Keratoacanthoma. Most cases are sporadic, but some people with inherited gene changes or genetic syndromes can be more prone to developing multiple Keratoacanthoma growths.
Diagnosis
Keratoacanthoma is usually diagnosed by a skin exam and a close look at how quickly the bump appeared and changed. Because it can resemble skin cancer, diagnosis of keratoacanthoma is often confirmed with a biopsy.
Treatment and drugs
Keratoacanthoma is usually treated by removing the growth, often with a small surgical procedure. Some people may instead have scraping with heat treatment, freezing, or medicine placed into the lesion. Follow-up matters because it can closely resemble skin cancer.
Symptoms
Keratoacanthoma usually appears as a new skin bump that grows quickly over a few weeks, often on sun-exposed areas such as the face, forearms, or hands. Day to day, it can feel like a spot that seemed small one week and suddenly becomes hard to ignore because it is raised, firm, and easy to catch while shaving or washing. Keratoacanthoma often forms a round lump with a central plug of dry material, and it can look a lot like a more serious skin cancer, so it needs prompt medical attention.
One of the early symptoms of keratoacanthoma is a skin bump that gets bigger over days to weeks, not months. Many living with keratoacanthoma notice that a spot that looked minor starts standing out quickly.
The spot is usually firm, round, and lifted above the skin, often like a smooth dome. For many, this can mean it rubs on clothing or is easy to notice when washing or shaving.
A plug of dry, rough material often forms in the middle, giving the bump a crater-like center. It can look as if the spot has a small hollow or core instead of a flat surface.
Keratoacanthoma is often skin-colored, pink, or red, and the nearby skin may look irritated. The color can make it resemble an inflamed pimple, boil, or another skin growth.
How people usually first notice Keratoacanthoma?
People usually first notice keratoacanthoma as a fast-growing bump on sun-exposed skin, often on the face, forearms, or backs of the hands, that can go from barely noticeable to about 1 to 2 centimeters, or roughly 0.4 to 0.8 inches, within a few weeks. One of the first warning signs of keratoacanthoma is that the bump often looks dome-shaped with a central plug of crust or keratin, a firm skin protein, which can make it resemble a small volcano or a rapidly changing sore. Because it grows quickly and can look a lot like squamous cell carcinoma, a common type of skin cancer, doctors usually recommend having any new rapidly enlarging skin lump checked promptly.
Types of Keratoacanthoma
Keratoacanthoma can show up in a few recognized forms, and the differences mostly relate to how many growths appear, how large they get, and where they develop. These types of Keratoacanthoma often look similar at first: a fast-growing, dome-shaped skin bump with a central plug of keratin, the tough material that also makes up nails. Symptoms don’t always look the same for everyone. For many, this can mean anything from one isolated spot on sun-exposed skin to several lesions that appear over a short time.
Solitary keratoacanthoma
This is the most common type and usually appears as a single round bump that grows quickly over a few weeks. Many people notice it on sun-exposed areas such as the face, forearms, or hands, where it can feel tender or become crusted. It may later flatten or shrink on its own, but it often needs treatment because it can closely resemble squamous cell skin cancer.
Giant keratoacanthoma
This variant is larger than the usual form, often growing beyond 2 cm, or about 0.8 inches, across. Because of its size, it can be more uncomfortable, more likely to break down or bleed, and more likely to leave a noticeable scar after treatment. Doctors usually remove it promptly because it can be hard to distinguish from a more aggressive skin tumor.
Multiple keratoacanthomas
In this form, several lesions appear instead of just one, sometimes over weeks to months. One person might struggle mostly with repeated new bumps, while another notices crops of lesions that settle and then recur. This pattern can be more disruptive in daily life because new growths may keep appearing on different parts of the skin.
Eruptive keratoacanthomas
This uncommon type involves many keratoacanthoma-like bumps appearing in a relatively short period of time. The lesions are often smaller than the solitary form, but the overall burden can be greater because of their number, itching, soreness, or cosmetic effect. Some people also develop them as part of a rare inherited syndrome.
Centrifugum marginatum
This rare variant tends to spread outward at the edges while the center starts to heal or flatten. Instead of forming one compact nodule, it can create a larger ring-shaped or expanding plaque over time. Having one type doesn’t necessarily mean you’ll develop the others.
Can I slow down the onset of symptoms?
Only to a limited extent: there is no proven way to reliably delay when a keratoacanthoma starts, but protecting your skin from too much sun and avoiding tanning beds may lower the risk because these fast-growing skin lumps are strongly linked to sun damage. This may help reduce risk, not prevent the condition, and the evidence for other steps is much less clear. Even so, steady sun protection is a worthwhile habit and can help protect your skin overall.
What genetics can tell you about symptoms
For most people with keratoacanthoma, genetics does not strongly predict the day-to-day symptoms, which are usually tied more to the growth itself, such as a fast-growing, dome-shaped skin bump with a central plug of keratin. Rare inherited conditions can make some people more likely to develop multiple growths or develop them at a younger age, so in those cases genetics may influence when keratoacanthomas appear and how many occur. Even then, genetic findings usually do not clearly forecast exactly how sore, inflamed, or bothersome an individual lesion will be.
Causes and risk factors
Most keratoacanthomas seem to develop after skin damage from ultraviolet light over many years. They are more common in older adults, in people with fair skin, and in those with a weakened immune system. Rarely, some people have an inherited tendency that makes keratoacanthoma more likely. Doctors distinguish between risk factors you can change and those you can’t. Common risk factors for keratoacanthoma include frequent sun exposure, tanning bed use, and sometimes skin injury, radiation, or certain chemical exposures.
What are the most common causes or risk factors?
The biggest risk factor for keratoacanthoma is long-term ultraviolet light exposure from the sun or tanning beds, especially in older adults with lighter skin. It is also more common in people with a weakened immune system, such as after an organ transplant, and it can sometimes show up after a skin injury or ongoing irritation. Rarely, inherited gene changes can raise the risk in some families, but most cases are not clearly caused by family history.
Environmental and biological risk factors
The main risk factors for keratoacanthoma are linked to skin damage from the environment and a few body-based traits that make skin more vulnerable. Doctors often group risks into internal (biological) and external (environmental). In most cases, long-term ultraviolet damage is the strongest driver, especially on skin that has already become more fragile with age or immune suppression.
Long-term exposure to ultraviolet light is the best-known environmental risk factor for keratoacanthoma. It often develops on areas that get years of sun, such as the face, ears, forearms, and backs of the hands.
Keratoacanthoma is seen most often in older adults, especially after middle age. This likely reflects skin changes and cell damage that build up over time.
People with lighter skin that burns easily have less natural protection against ultraviolet radiation. That can raise the chance of keratoacanthoma after repeated exposure over many years.
A weakened immune system can make it harder for the body to clear damaged or abnormal skin cells. Keratoacanthoma is more common in people taking immune-suppressing medicines or living with conditions that reduce immune defenses.
Genetic risk factors
For most people, keratoacanthoma shows up as a fast-growing skin bump that seems to appear out of nowhere, but in a small number of families there is a clear inherited tendency. Some risk factors are inherited through our genes. When people ask about genetic risk factors for keratoacanthoma, the main concerns are rare inherited syndromes and gene changes found in the growth itself. Most cases are still thought to be sporadic, meaning they do not come from a known family-wide gene change.
Family history: A close family pattern of repeated keratoacanthomas or similar skin tumors can suggest an inherited tendency. This is uncommon, but it matters more when several relatives have had fast-growing crater-like skin growths or repeated skin cancers.
Ferguson-Smith syndrome: This rare inherited condition can cause multiple keratoacanthoma-like tumors that often heal on their own over time. It involves a gene change in a pathway that helps put the brakes on skin cell growth.
Muir-Torre syndrome: This inherited cancer syndrome, a form of Lynch syndrome, affects genes that normally repair DNA mistakes. People living with it can develop keratoacanthomas along with other skin tumors and a higher risk of certain internal cancers.
Xeroderma pigmentosum: This rare inherited disorder makes it hard for skin cells to repair DNA damage. People with xeroderma pigmentosum have a very high risk of skin tumors, and keratoacanthomas can be part of that picture.
Tumor gene changes: Some keratoacanthomas contain gene changes that arise only in the tumor, not in the rest of the body. These changes may drive the rapid growth of the bump, but they usually do not mean family members share the same risk.
Lifestyle risk factors
Lifestyle plays a smaller role in keratoacanthoma than it does in many chronic diseases, but certain habits can still influence risk and recurrence. The clearest behavior-linked factor is repeated ultraviolet exposure from outdoor activities or tanning practices. When people ask about lifestyle risk factors for keratoacanthoma, the main focus is usually on sun-related habits, with smoking and skin injury discussed more cautiously because the evidence is less consistent. Healthy daily habits do not guarantee prevention, but they may lower avoidable triggers that affect the skin.
Frequent unprotected time in strong sunlight can increase cumulative skin damage that may contribute to keratoacanthoma development. Regular use of shade, protective clothing, and broad-spectrum sunscreen may help reduce this risk.
Tanning beds expose the skin to intense ultraviolet radiation that can promote abnormal growth in sun-sensitive skin. Avoiding indoor tanning is one of the most relevant ways how lifestyle affects keratoacanthoma risk.
Long hours outdoors without protective routines can lead to repeated ultraviolet injury over time. Scheduling breaks in shade and wearing hats or sun-protective clothing may lower ongoing damage.
Smoking may impair normal skin repair and has been linked in some studies to a higher risk of certain skin tumors, although the association with keratoacanthoma is not as strong as for sun exposure. Quitting smoking may support healthier skin healing and reduce compounding risks.
Risk prevention
Keratoacanthoma often appears as a fast-growing bump on sun-exposed skin, so prevention mainly focuses on lowering damage to the skin rather than guaranteeing it will never happen. The clearest step to reduce the risk of keratoacanthoma is protecting your skin from ultraviolet light, including daily sun exposure and tanning beds. Prevention is about lowering risk, not eliminating it completely.
Use a broad-spectrum sunscreen with SPF 30 or higher on exposed skin, and reapply it if you stay outdoors. Hats, long sleeves, and shade can further lower ultraviolet damage that may trigger keratoacanthoma.
Tanning beds expose skin to concentrated ultraviolet light and can raise the chance of skin tumors. Skipping indoor tanning is one of the simplest ways to help prevent keratoacanthoma and other skin cancers.
Regular skin checks can help you spot a new dome-shaped bump early, especially on the face, hands, forearms, and other sun-exposed areas. If a growth appears quickly over a few weeks, see a doctor promptly because early symptoms of keratoacanthoma can look like other skin cancers.
Try to avoid repeated sunburns and protect skin during outdoor work, driving, sports, and gardening. Prevention works best when it becomes part of daily life, not a special project.
Can you prevent Keratoacanthoma?
You cannot fully prevent keratoacanthoma, because it can happen even when there is no clear cause. Still, you may be able to lower the risk by protecting your skin from too much sun, avoiding tanning beds, and getting any new, fast-growing skin bump checked early.
Transmission
Keratoacanthoma is not an infectious condition, so it does not spread from one person to another through touching, kissing, sharing items, or close contact. Many people ask whether keratoacanthoma is contagious, but the answer is no. It usually develops from changes within the skin itself, often on sun-exposed areas, rather than from a virus or other germ. In most cases, keratoacanthoma is also not something that is directly passed down in families, although rare inherited syndromes can make multiple similar skin growths more likely.
When to test your genes
For keratoacanthoma, genetic testing is not routine because most cases are isolated and not inherited. It may be worth discussing if you have many recurrent lesions, a strong family history of similar skin tumors, or features suggesting a rare inherited syndrome, because results could guide screening and follow-up.
Diagnosis
Keratoacanthoma is usually diagnosed after a new, fast-growing skin lump brings someone in for a checkup. Because it can look a lot like squamous cell skin cancer, doctors often need to examine it closely and confirm the diagnosis of keratoacanthoma with a tissue sample. It’s natural to worry when symptoms don’t have a clear explanation.
Doctors look at how quickly the spot appeared, where it is, and whether it has the classic dome shape with a central plug of keratin, the hard material found in skin and nails. They also check for warning signs such as bleeding, crusting, pain, or nearby skin changes.
A handheld lighted magnifier can help your doctor see surface patterns that are not visible to the naked eye. This may support the diagnosis, but it usually cannot fully rule out squamous cell skin cancer on its own.
A biopsy is the main test because keratoacanthoma and squamous cell carcinoma can look very similar. Doctors remove part or all of the growth so a specialist can examine the tissue under a microscope.
The lab looks for a crater-like shape, thickened skin cells, and the central keratin-filled core that often fits keratoacanthoma. Even with these features, some cases are hard to separate cleanly from squamous cell carcinoma, so the report may be cautious.
How is Keratoacanthoma diagnosed?
Keratoacanthoma is usually diagnosed by a skin doctor looking closely at the lump and asking how quickly it appeared and changed, since it often grows fast over a few weeks. Because it can look a lot like a common skin cancer called squamous cell carcinoma, doctors usually confirm the diagnosis by removing all or part of the bump and checking the tissue under a microscope. Scans and genetic tests are not usually needed.
Stages of Keratoacanthoma
Keratoacanthoma usually follows a fairly predictable course rather than formal numbered stages. In many people, it appears quickly over a few weeks, may stay about the same for a short time, and can then shrink on its own, although doctors often still recommend treatment because it can look very similar to a type of skin cancer. Early and accurate diagnosis helps you plan ahead with confidence.
Rapid growth
This first phase is when a keratoacanthoma grows fast, often over 2 to 8 weeks. You may notice a firm, dome-shaped bump with a central plug of keratin, which is one of the early symptoms of keratoacanthoma. It may become large enough to catch on clothing or feel tender.
Stable phase
After the quick growth period, the spot may stop changing much for a time. During this phase, keratoacanthoma often keeps its round crater-like shape and may look alarming even if it is not causing much discomfort.
Shrinking phase
Some keratoacanthomas then begin to get smaller on their own over the following weeks to months. As this happens, the center may flatten and the area can leave a scar once it heals.
Outlook and prognosis
The outlook for keratoacanthoma is generally excellent, because many lesions grow rapidly for a few weeks to months and may then stabilize and even regress on their own over several months. However, prognosis is usually discussed cautiously because keratoacanthoma can closely resemble cutaneous squamous cell carcinoma, so most clinicians recommend prompt biopsy and complete removal rather than observation alone. When fully excised, recurrence is uncommon, although new lesions can occur in people with significant sun damage or multiple prior skin tumors. Mortality from a typical solitary keratoacanthoma is extremely low, but prognosis becomes more serious if a lesion is actually an invasive squamous cell carcinoma or if diagnosis and treatment are delayed. Long-term outlook is best with regular skin surveillance and sun protection, especially in older adults and immunosuppressed patients.
Long-term effects
Keratoacanthoma often affects daily life because it appears quickly, usually on sun-exposed skin, and can leave a mark even after it is treated or settles down. Many people living with keratoacanthoma do well long term, especially when the growth is removed and checked under a microscope. Long-term effects vary widely, but most relate to the skin itself rather than to overall health. Because keratoacanthoma can closely mimic a more serious skin cancer, follow-up sometimes matters as much as the growth itself.
A lasting scar or change in skin texture is one of the most common long-term effects of keratoacanthoma. This can be more noticeable on the face, ears, hands, or other areas that are hard to cover.
Even after healing, the skin may stay lighter, darker, pinker, or slightly sunken where the keratoacanthoma was. For many, this is more of a cosmetic concern than a medical problem, but it can still be upsetting.
If a keratoacanthoma grows large before treatment, it can stretch or damage nearby skin and leave a broader defect after removal. This may matter more in delicate areas such as the nose, eyelid, or lip.
Most keratoacanthomas do not keep coming back after complete treatment, but some people develop another similar growth later on. This can happen in the same area or on other sun-exposed skin.
How is it to live with Keratoacanthoma?
Living with keratoacanthoma often means dealing with a skin growth that appears quickly over a few weeks, which can be unsettling because it may become large, tender, or easy to bump, shave, or catch on clothing depending on where it sits. For many people, the hardest part is the uncertainty and the need for prompt medical visits, biopsy, and usually removal, since it can closely resemble a type of skin cancer called squamous cell carcinoma. Daily life is usually affected more by worry, appearance changes, and minor discomfort than by major physical limits, and people around you may also feel anxious until the diagnosis is clear and treatment is completed.
Treatment and drugs
Keratoacanthoma is usually treated by removing the growth, because it can look very similar to a type of skin cancer called squamous cell carcinoma and doctors often cannot safely tell the difference without treating it. In many cases, treatment is a small procedure done under local anesthetic, such as cutting out the lump or scraping it away and sealing the area with heat. For some people, especially if the keratoacanthoma is large, in a tricky spot, or there are several growths, doctors may also consider treatments placed into the lesion or, less often, medicines taken by mouth. Treatment plans often combine several approaches. After treatment, follow-up visits help check healing, confirm the diagnosis under the microscope, and watch for any new or returning spots.
Can you cure Keratoacanthoma?
Keratoacanthoma can often be cured by removing the growth completely, so treatment is usually very successful. Doctors usually recommend a minor skin procedure to take it off because it can look very similar to a more serious skin cancer and may keep growing or leave a scar. Even though some spots may go away on their own, treatment and follow-up are still important, and some people can develop a new spot later.
Non-drug treatment
Treatment for Keratoacanthoma is usually procedural rather than medicine-based, because the goal is to remove the fast-growing skin lump and confirm exactly what it is under the microscope. For many people, the best treatment for keratoacanthoma is a minor skin procedure done with local numbing in an office or clinic. Not every approach works the same way, so the choice depends on the size of the growth, where it sits, and whether it may be hard to tell apart from squamous cell skin cancer.
This is the most common treatment and removes the growth along with a small rim of nearby skin. It gives the lab enough tissue to confirm the diagnosis and lowers the chance of the spot coming back.
Mohs removes the growth layer by layer while each layer is checked right away under a microscope. It is often used when Keratoacanthoma is on the face, ears, lips, hands, or other areas where saving healthy skin matters.
In some cases, the growth can be scraped away and the base treated with heat or electricity to destroy remaining cells. This may be an option for smaller lesions, though it does not suit every Keratoacanthoma.
Freezing the lesion with very cold liquid can sometimes be used for small, selected growths. It is less commonly chosen when there is concern about deeper spread or when a full tissue sample is needed.
Your genes may have an impact on how drugs work for you
For keratoacanthoma, treatment is usually a procedure to remove the growth rather than long-term medicine, so genetic differences do not usually play a big part in day-to-day treatment choices. In the less common situation where medicine is used, such as certain skin-directed or anti-cancer treatments, people can still respond differently, and part of that may be due to inherited differences that affect how the body breaks down medicine or how sensitive it is to side effects. Even so, this kind of gene-based drug planning is not a routine part of care for keratoacanthoma at this time.
Pharmacological treatments
Medicines are not the main treatment for keratoacanthoma, because doctors usually prefer to remove the growth and confirm the diagnosis under a microscope. Still, drug treatment may be used when surgery is difficult, when there are several lesions, or when the growth is in a place where scarring matters more. Finding the right medication can be a process of trial, patience, and adjustment. In practice, treatment is chosen case by case, because keratoacanthoma can look very similar to squamous cell skin cancer.
Methotrexate is one of the best-known drug options for keratoacanthoma when doctors want to shrink the lesion without immediate surgery. It is often injected directly into the bump, and many lesions flatten over days to weeks. Blood tests and follow-up are important because this medicine can affect the liver, bone marrow, and kidneys.
5-fluorouracil, often called 5-FU, may be injected into the lesion and can help destroy fast-growing abnormal skin cells. It may be considered for people who cannot have surgery right away or want a less invasive approach. In some cases, this can help with early treatment of keratoacanthoma before the growth becomes larger and more bothersome.
Bleomycin is another medicine that can be injected into a keratoacanthoma, although it is used less often than methotrexate or 5-FU. It may help certain stubborn lesions shrink when other local treatments are not suitable. The treated area can become painful, inflamed, or crusted as it heals.
Oral retinoids such as acitretin or isotretinoin may be used for people with multiple keratoacanthomas or repeated new lesions. These medicines work by changing how skin cells grow and mature, rather than attacking one bump at a time. They are not safe during pregnancy and may cause dry skin, dry lips, and changes in blood fat levels or liver tests.
Genetic influences
Many people ask whether keratoacanthoma is hereditary, especially when similar fast-growing skin bumps have shown up in more than one relative. In most cases, keratoacanthoma is not caused by a single inherited gene; sun exposure, older age, and other skin damage seem to matter more. Family history is one of the strongest clues to a genetic influence, particularly if someone develops several keratoacanthomas, gets them at a younger age, or has relatives with the same kind of growth. A small number of people have an inherited condition that raises the chance of keratoacanthoma or related skin cancers. Doctors also know that gene changes can arise only in the growth itself over time, which is different from being born with a gene change. If keratoacanthoma keeps recurring or many family members are affected, genetic counseling may help sort out whether inherited risk is part of the picture.
Is Keratoacanthoma genetic?
Genetics usually are not the main driver of Keratoacanthoma. Most cases are sporadic, but some people with inherited gene changes or genetic syndromes can be more prone to developing multiple Keratoacanthoma growths.
Having a genetic risk is not necessarily a diagnosis
Variants in genes are a usual part of being human and are found throughout the general population. Most of these variants do not directly affect health; they are just one aspect of normal human diversity. In many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when more than one gene and environmental factors play a role. Still, in some situations, one well-understood variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For most people with keratoacanthoma, genetics do not decide the main treatment, because care usually focuses on removing the fast-growing skin bump and making sure it is not squamous cell skin cancer, which can look very similar. If you are wondering how genetics affect treatment for keratoacanthoma, there is currently no routine gene-based test used to choose between surgery, scraping and cautery, or medicine injected into the growth. Not every difference in response is genetic, but genes may matter more in the uncommon situation where keratoacanthoma shows up as part of an inherited condition or when someone develops many lesions over time. In those cases, a dermatologist or genetics specialist may look more closely at family history and decide whether closer follow-up or less common treatments, such as vitamin A-like tablets, should be considered. For many living with keratoacanthoma, treatment choices are still guided much more by the size, location, growth pattern, and biopsy results than by genetic testing.
Interactions with other conditions
A fast-growing bump on sun-exposed skin can be worrying because keratoacanthoma often looks a lot like squamous cell skin cancer, especially in the early symptoms of keratoacanthoma when the center may start to form a plug of keratin. This means doctors usually need a close skin exam and often a biopsy to tell whether it is truly keratoacanthoma or a cancer that needs prompt treatment. Another important aspect is how it may link with other diseases. People with weakened immune systems, including those taking anti-rejection medicines after an organ transplant or living with certain blood disorders, can have a higher chance of developing keratoacanthoma and other skin tumors. Many living with keratoacanthoma also have long-term sun damage, so other growths such as actinic keratoses, basal cell carcinoma, or squamous cell carcinoma may be present at the same time. In some families, repeated or multiple keratoacanthomas are part of a rare inherited tendency to skin tumors, which is one reason doctors may ask about family history as well as your overall health.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Keratoacanthoma?
Keratoacanthoma can look a lot like other skin growths, especially squamous cell skin cancer, which is the most important one doctors want to rule out. It can also be mistaken for basal cell skin cancer, a common wart, or an inflamed cyst because these can all cause a fast-growing, raised bump that may have a crusted or plugged center.
History
People living with keratoacanthoma often notice a skin bump that seems to appear quickly over a few weeks, which is one reason it drew medical attention early. First described in the medical literature in the late 1800s, it was noted as a fast-growing, dome-shaped lesion with a central plug of keratin, the tough material that also makes up the outer layer of skin, hair, and nails. Early doctors were struck by how these growths could look alarming at first and then, in some cases, shrink on their own.
As more cases were reported in the 1900s, doctors began to realize that keratoacanthoma could closely resemble squamous cell carcinoma, a common form of skin cancer. Over time, the way the condition has been understood has changed, and medical classifications shifted as specialists compared how it looked under the microscope, how fast it grew, and how it behaved after treatment. For many years, some experts treated it as a separate growth, while others saw it as part of the same broader family as squamous cell carcinoma.
That debate still shapes care today. Many clinicians now view keratoacanthoma as a lesion that can be hard to tell apart from squamous cell carcinoma, especially in its early stages, so it is usually treated rather than simply watched. This helps explain why the history of keratoacanthoma is not just about naming a skin condition, but about learning how to respond safely when a rapidly growing skin nodule appears.
In recent decades, better pathology methods and broader research have made diagnosis more consistent, even though gray areas remain. Knowing this history can make current advice feel more understandable: if a doctor recommends prompt removal or a biopsy for suspected keratoacanthoma, it is largely because the early symptoms of keratoacanthoma can overlap with skin cancers that need treatment.